A detailed history of Puzo Michael J transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Puzo Michael J holds 12,237 shares of VRTX stock, worth $5.52 Million. This represents 1.52% of its overall portfolio holdings.

Number of Shares
12,237
Previous 9,566 27.92%
Holding current value
$5.52 Million
Previous $4.48 Million 26.95%
% of portfolio
1.52%
Previous 1.26%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$460.0 - $505.78 $1.23 Million - $1.35 Million
2,671 Added 27.92%
12,237 $5.69 Million
Q2 2024

Aug 12, 2024

BUY
$392.81 - $485.53 $1.95 Million - $2.4 Million
4,953 Added 107.37%
9,566 $4.48 Million
Q1 2024

May 13, 2024

BUY
$407.69 - $446.08 $1.53 Million - $1.68 Million
3,763 Added 442.71%
4,613 $1.93 Million
Q4 2023

Feb 13, 2024

BUY
$343.0 - $410.68 $291,550 - $349,078
850 New
850 $345,000
Q4 2019

Jan 15, 2020

SELL
$166.71 - $223.91 $458,452 - $615,752
-2,750 Closed
0 $0
Q1 2019

May 01, 2019

SELL
$163.73 - $194.7 $32,745 - $38,940
-200 Reduced 6.78%
2,750 $506,000
Q4 2018

Jan 24, 2019

SELL
$151.91 - $192.21 $7,595 - $9,610
-50 Reduced 1.67%
2,950 $489,000
Q1 2018

Apr 24, 2018

BUY
$151.6 - $177.13 $454,800 - $531,390
3,000 New
3,000 $488,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $116B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Puzo Michael J Portfolio

Follow Puzo Michael J and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Puzo Michael J, based on Form 13F filings with the SEC.

News

Stay updated on Puzo Michael J with notifications on news.